Site US00090 — Washington D.C., District of Columbia

Site US00090 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US00090 has participated in 1 clinical trials.

Therapeutic areas: Overactive Bladder (OAB).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00090?

Site US00090 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00090 conducted?

Site US00090 has 1 clinical trials on record. Their work covers Overactive Bladder (OAB).

Is Site US00090 accredited by Crixeo Health?

Site US00090 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00090?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.